Dare Bioscience DARE will release its quarterly earnings report on Thursday, 2024-11-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Dare Bioscience to report an earnings per share (EPS) of $-0.73.
Investors in Dare Bioscience are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Here's a look at Dare Bioscience's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.72 | -1.20 | -1.20 | |
| EPS Actual | 1.52 | -0.84 | -0.72 | -1.08 |
| Price Change % | 20.0% | 14.000000000000002% | -11.0% | 0.0% |
Dare Bioscience Share Price Analysis
Shares of Dare Bioscience were trading at $4.41 as of November 12. Over the last 52-week period, shares are up 6.47%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Dare Bioscience visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
